Modified pectin and nucleic acid composition
US6500807B1 · kind B1 · utility
23Cited by
31References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 1, 2000 |
| Grant date | Dec 31, 2002 |
| Priority date | — |
| Expiry date | Feb 1, 2020 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/45
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
According to the present invention, there is provided a gene therapy material which includes a nucleic acid material and a carbohydrate wherein the carbohydrate preferably is a modified pectin. Also in accordance with the present invention, there is provided a gene therapy material including a nucleic acid material, a carbohydrate material associated with the nucleic acid material, and a protective coating disposed about the carbohydrate material.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.